+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Atenolol"

From
From
Atenolol (CAS 29122-68-7) Global Market Research Report 2024 - Product Thumbnail Image

Atenolol (CAS 29122-68-7) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Atenolol is a beta-blocker drug used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. It works by blocking the action of certain natural chemicals in the body, such as epinephrine, that affect the heart and blood vessels. Atenolol is usually taken once or twice daily, with or without food. It is available in tablet, capsule, and liquid form. Atenolol is a widely used drug in the cardiovascular market, as it is effective in treating a variety of conditions. It is also relatively inexpensive compared to other drugs in the same class. Additionally, it has a low risk of side effects, making it a popular choice for many patients. In the Atenolol market, some of the major players include Pfizer, Novartis, Merck, and GlaxoSmithKline. Other companies such as Mylan, Teva, and Sandoz also produce generic versions of the drug. Show Less Read more